Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors

Published:2022-03-05 Issue:6 Volume:15 Page:1430-1438
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Kim Sarah¹^ORCID,Lahu Gezim²,Vakilynejad Majid³,Soldatos Theodoros G.⁴,Jackson David B.⁴,Lesko Lawrence J.¹,Trame Mirjam N.¹

Affiliation:

1. Center for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics College of Pharmacy University of Florida Orlando Florida USA

2. thinkQ2 Baar Switzerland

3. Takeda Oncology Cambridge Massachusetts USA

4. Molecular Health GmbH Heidelberg Germany

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13254

Reference47 articles.

1. YERVOY (ipilimumab) injection label from FDA website.U.S. Food and Drug Administration 2018.https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125377s094lbl.pdf.

2. OPDIVO (nivolumab) label from FDA website.U.S. Food and Drug Administration 2019.https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125554s070lbl.pdf.

3. KEYTRUDA (pembrolizumab) label from FDA website.U.S. Food and Drug Administration 2019.https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125514s040lbl.pdf.

4. Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities

5. Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rewiring Drug Research and Development through Human Data-Driven Discovery (HD3);Pharmaceutics;2023-06-07